- Home
- PESI vs ACHV Comparison
PESI vs ACHV Comparison
Compare PESI & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PESI | ACHV |
|---|---|---|
| Founded | 1990 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Environmental Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 231.8M | 239.0M |
| IPO Year | 1992 | N/A |
Fundamental Metrics
Financial Performance| Metric | PESI | ACHV |
|---|---|---|
| Price | $12.67 | $4.46 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $15.50 |
| AVG Volume (30 Days) | 103.5K | ★ 599.7K |
| Earning Date | 11-10-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $60,661,000.00 | N/A |
| Revenue This Year | $9.91 | N/A |
| Revenue Next Year | $62.48 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.25 | $1.84 |
| 52 Week High | $16.50 | $5.78 |
Technical Indicators
Market Signals| Indicator | PESI | ACHV |
|---|---|---|
| Relative Strength Index (RSI) | 43.64 | 49.77 |
| Support Level | $12.70 | $4.25 |
| Resistance Level | $13.74 | $4.52 |
| Average True Range (ATR) | 0.54 | 0.22 |
| MACD | -0.15 | -0.03 |
| Stochastic Oscillator | 7.87 | 31.54 |
Price Performance
Historical ComparisonAbout PESI Perma-Fix Environmental Services Inc.
Perma-Fix Environmental Services Inc is a provider of both nuclear services and the management of nuclear and mixed waste. The company operates through two segments: The treatment segment offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.